TSE:CRON

Cronos Group Stock Forecast, Price & News

C$10.43

+0.26 (+2.56 %)

(As of 04/16/2021 12:00 AM ET)

Add

Compare

Today's Range

C$9.94

Now: C$10.43▼

C$10.48

50-Day Range

C$10.17

MA: C$12.10▼

C$13.97

52-Week Range

C$6.54

Now: C$10.43▼

C$20.08

Volume338,338 shs

Average Volume998,247 shs

Market CapitalizationC$3.76 billion

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Cronos Group Inc. operates as a cannabinoid company in the United States and internationally. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through ecommerce, retail, and hospitality partner channels. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. Its brand portfolio includes PEACE NATURALS, a global wellness platform; adult-use brands comprise COVE and Spinach; and hemp-derived CBD brands consists of Lord Jones and PEACE+. Cronos Group Inc. is based in Toronto, Canada.

Industry, Sector and Symbol

Stock Exchange TSE

Industry Biotechnology

Sub-IndustryN/A

SectorMedical

Current SymbolTSE:CRON

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.thecronosgroup.com

Phone416-504-0004

Employees631

Year FoundedN/A

Debt

Debt-to-Equity Ratio0.58

Current Ratio6.63

Quick Ratio6.33

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E Growth-0.95

Sales & Book Value

Annual SalesC$46.72 million

Price / Sales80.43

Cash FlowC$3.67 per share

Price / Cash Flow2.84

Book ValueC$4.75 per share

Price / Book2.20

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

Outstanding Shares360,259,000

Market CapC$3.76 billion

Next Earnings DateN/A

OptionableOptionable

Headlines

Altria (MO) Looks Steady on Low-Risk Products & Strong Pricing
April 16, 2021 | msn.com

Stocks Take Breather from Records
April 12, 2021 | ca.finance.yahoo.com

Cronos Group Enters Oversold Territory (CRON)
April 12, 2021 | nasdaq.com

The Week In Cannabis: Glass House, Canopy, Curaleaf, Trulieve, Virginia And More
April 9, 2021 | msn.com

Cronos Group (TSE:CRON) Given New C$5.90 Price Target at Jefferies Financial Group
April 9, 2021 | americanbankingnews.com

7 Great Stocks to Buy Under $10
April 8, 2021 | investorplace.com

CRON May 28th Options Begin Trading
April 8, 2021 | nasdaq.com

Top 3 Value-Priced Pot Stocks to Buy Now
April 2, 2021 | msn.com

Cronos Group (TSE:CRON) Stock Price Down 1.2%
March 30, 2021 | americanbankingnews.com

Indexes Retreat, Weighed by Health-Care
March 23, 2021 | baystreet.ca

The 5 Most Popular Pot Stocks on Robinhood: Are They Buys?
March 22, 2021 | msn.com

First Week of CRON May 21st Options Trading
March 19, 2021 | nasdaq.com

Estimating The Fair Value Of Cronos Group Inc. (TSE:CRON)
March 4, 2021 | finance.yahoo.com

Top Marijuana Stock Times New CBD Drink Launch With Astrological Event
March 2, 2021 | finance.yahoo.com

Marijuana Stocks: Canopy Growth Launches CBD Beverages In The U.S.
March 2, 2021 | finance.yahoo.com

Company News for Mar 1, 2021
March 1, 2021 | finance.yahoo.com

Canadian Market Holds In Positive Territory As Healthcare Stocks Rebound
February 19, 2021 | markets.businessinsider.com

CANADA STOCKS-TSX jumps to record high on energy boost, U.S. stimulus hopes
February 16, 2021 | nasdaq.com

TSX Records Fresh Closing High As Healthcare, Energy Stocks Rally
February 10, 2021 | markets.businessinsider.com

Canadian Market Falters After Hitting Fresh Record High; Cannabis Shares Shine
February 10, 2021 | nasdaq.com

See More Headlines

MarketRank^™

Overall MarketRank^™

0.69 out of 5 stars

1.3 Analyst's Opinion

Consensus Rating
Cronos Group has received a consensus rating of Buy. The company's average rating score is 2.67, and is based on 2 buy ratings, 1 hold rating, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of C$9.68, Cronos Group has a forecasted downside of 7.2% from its current price of C$10.43.
Amount of Analyst Coverage
Cronos Group has only been the subject of 3 research reports in the past 90 days.

2.1 Community Rank

Outperform Votes
Cronos Group has received 60 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Cronos Group has received 82 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Cronos Group has received 57.75% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Cronos Group and other stocks. Vote “Outperform” if you believe CRON will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CRON will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Cronos Group does not currently pay a dividend.
Dividend Growth
Cronos Group does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Cronos Group insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Cronos Group is -39.21, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Cronos Group is -39.21, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Growth Ratio
Due to a projected decrease in earnings for Cronos Group, their PEG ratio cannot be calculated.
Price to Book Value per Share Ratio
Cronos Group has a P/B Ratio of 2.20. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

C$10.43

+0.26 (+2.56 %)

(As of 04/16/2021 12:00 AM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive CRON News and Ratings via Email

Sign-up to receive the latest news and ratings for CRON and its competitors with MarketBeat's FREE daily newsletter.

Cronos Group (TSE:CRON) Frequently Asked Questions

Is Cronos Group a buy right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cronos Group in the last twelve months. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Cronos Group stock.
View analyst ratings for Cronos Group or view top-rated stocks.

What stocks does MarketBeat like better than Cronos Group?

Wall Street analysts have given Cronos Group a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Cronos Group wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How has Cronos Group's stock price been impacted by Coronavirus (COVID-19)?

Cronos Group's stock was trading at C$7.45 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, CRON stock has increased by 40.0% and is now trading at C$10.43.
View which stocks have been most impacted by COVID-19.

What price target have analysts set for CRON?

3 Wall Street analysts have issued 1 year price objectives for Cronos Group's stock. Their forecasts range from C$5.90 to C$14.00. On average, they anticipate Cronos Group's share price to reach C$9.68 in the next year. This suggests that the stock has a possible downside of 7.2%.
View analysts' price targets for Cronos Group or view top-rated stocks among Wall Street analysts.

Who are Cronos Group's key executives?

Cronos Group's management team includes the following people:

Mr. Michael Ryan Gorenstein, Exec. Chairman (Age 34, Pay $333.57k)
Mr. Jerry Filomena Barbato, Chief Financial Officer (Age 45, Pay $299.63k)
Ms. Xiuming Shum, Exec. VP of Legal and Regulatory Affairs & Corp. Sec. (Age 35, Pay $190.18k)
Mr. Kurt Thomas Schmidt B.Sc., M.B.A., Pres & CEO (Age 64)
Mr. Shayne J. Laidlaw, Director of Investor Relations & Strategy
Ms. Shannon Buggy, Sr. VP & Global Head of People
Ms. Anna Shlimak, Sr. VP of Corp. Affairs (Age 35)
Dr. Todd K. Abraham, Chief Innovation Officer (Age 66)
Puneet Mathur, VP & Controller
Ms. Summer Frein, Gen. Mang. of USA (Age 37)

Who are some of Cronos Group's key competitors?

Some companies that are related to Cronos Group include AbCellera Biologics (ABCL), Sana Biotechnology (SANA), Abcam (ABCM), Genus (GNS), Abcam (ABC), BTG (BTG), Seer (SEER), MorphoSys (MOR), Nuvation Bio (NUVB), ImmunityBio (IBRX), Immunocore (IMCR), BioAtla (BCAB), Cullinan Oncology (CGEM), Silverback Therapeutics (SBTX) and Kinnate Biopharma (KNTE).
View all of CRON's competitors.

What other stocks do shareholders of Cronos Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cronos Group investors own include Aurora Cannabis (ACB), (CGC), Aurora Cannabis (ACB), Canopy Growth (WEED), NVIDIA (NVDA), Aphria (APHA), Advanced Micro Devices (AMD), Netflix (NFLX), The Walt Disney (DIS) and Intel (INTC).

What is Cronos Group's stock symbol?

Cronos Group trades on the Toronto Stock Exchange (TSX) under the ticker symbol "CRON."

How do I buy shares of Cronos Group?

Shares of CRON and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Cronos Group's stock price today?

One share of CRON stock can currently be purchased for approximately C$10.43.

How much money does Cronos Group make?

Cronos Group has a market capitalization of C$3.76 billion and generates C$46.72 million in revenue each year.

How many employees does Cronos Group have?

Cronos Group employs 631 workers across the globe.

What is Cronos Group's official website?

The official website for Cronos Group is www.thecronosgroup.com.

How can I contact Cronos Group?

The company can be reached via phone at 416-504-0004.

This page was last updated on 4/17/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here